Literature DB >> 12560779

Portal vein embolization before right hepatectomy: prospective clinical trial.

Olivier Farges1, Jacques Belghiti, Reza Kianmanesh, Jean Marc Regimbeau, Roberto Santoro, Valérie Vilgrain, Alban Denys, Alain Sauvanet.   

Abstract

OBJECTIVE: To assess the impact of liver hypertrophy of the future liver remnant volume (FLR) induced by preoperative portal vein embolization (PVE) on the immediate postoperative complications after a standardized major liver resection. SUMMARY BACKGROUND DATA: PVE is usually indicated when FLR is estimated to be too small for major liver resection. However, few data exist regarding the exact quantification of sufficient minimal functional hepatic volume required to avoid postoperative complications in both patients with or without chronic liver disease.
METHODS: All consecutive patients in whom an elective right hepatectomy was feasible and who fulfilled the inclusion and exclusion criteria between 1998 and 2000 were assigned to have alternatively either immediate surgery or surgery after PVE. Among 55 patients (25 liver metastases, 2 cholangiocarcinoma, and 28 hepatocellular carcinoma), 28 underwent right hepatectomy after PVE and 27 underwent immediate surgery. Twenty-eight patients had chronic liver disease. FLR and estimated rate of functional future liver remnant (%FFLR) volumes were assessed by computed tomography.
RESULTS: The mean increase of FLR and %FFLR 4 to 8 weeks after PVE were respectively 44 +/- 19% and 16 +/- 7% for patients with normal liver and 35 +/- 28% and 9 +/- 3% for those with chronic liver disease. All patients with normal liver and 86% with chronic liver disease experienced hypertrophy after PVE. The postoperative course of patients with normal liver who underwent PVE before right hepatectomy was similar to those with immediate surgery. In contrast, PVE in patients with chronic liver disease significantly decreased the incidence of postoperative complications as well as the intensive care unit stay and total hospital stay after right hepatectomy.
CONCLUSIONS: Before elective right hepatectomy, the hypertrophy of FLR induced by PVE had no beneficial effect on the postoperative course in patients with normal liver. In contrast, in patients with chronic liver disease, the hypertrophy of the FLR induced by PVE decreased significantly the rate of postoperative complications.

Entities:  

Mesh:

Year:  2003        PMID: 12560779      PMCID: PMC1522143          DOI: 10.1097/01.SLA.0000048447.16651.7B

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  50 in total

1.  Hepatic metastases from colorectal cancer: influence of hepatic volumetric analysis on surgical decision making.

Authors:  P Soyer; A Roche; D Elias; M Levesque
Journal:  Radiology       Date:  1992-09       Impact factor: 11.105

2.  Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases.

Authors:  Y Fong; J Fortner; R L Sun; M F Brennan; L H Blumgart
Journal:  Ann Surg       Date:  1999-09       Impact factor: 12.969

3.  Resection for multiple metastatic liver tumors after portal embolization.

Authors:  S Kawasaki; M Makuuchi; T Kakazu; S Miyagawa; T Takayama; T Kosuge; K Sugihara; Y Moriya
Journal:  Surgery       Date:  1994-06       Impact factor: 3.982

4.  Predictive value of ASA classification for the assessment of the perioperative risk.

Authors:  H Menke; A Klein; K D John; T Junginger
Journal:  Int Surg       Date:  1993 Jul-Sep

5.  Comparison of outcome between extended and nonextended liver resections for neoplasms.

Authors:  J N Vauthey; H U Baer; T Guastella; L H Blumgart
Journal:  Surgery       Date:  1993-11       Impact factor: 3.982

6.  Trends in morbidity and mortality of hepatic resection for malignancy. A matched comparative analysis.

Authors:  J I Tsao; J P Loftus; D M Nagorney; M A Adson; D M Ilstrup
Journal:  Ann Surg       Date:  1994-08       Impact factor: 12.969

7.  One hundred consecutive hepatic resections. Blood loss, transfusion, and operative technique.

Authors:  J D Cunningham; Y Fong; C Shriver; J Melendez; W L Marx; L H Blumgart
Journal:  Arch Surg       Date:  1994-10

8.  Changes in hepatic lobe volume in biliary tract cancer patients after right portal vein embolization.

Authors:  M Nagino; Y Nimura; J Kamiya; S Kondo; K Uesaka; Y Kin; N Hayakawa; H Yamamoto
Journal:  Hepatology       Date:  1995-02       Impact factor: 17.425

9.  Hospital mortality of major hepatectomy for hepatocellular carcinoma associated with cirrhosis.

Authors:  S T Fan; E C Lai; C M Lo; I O Ng; J Wong
Journal:  Arch Surg       Date:  1995-02

10.  Radical operation after portal embolization for tumor of hilar bile duct.

Authors:  S Kawasaki; M Makuuchi; S Miyagawa; T Kakazu
Journal:  J Am Coll Surg       Date:  1994-05       Impact factor: 6.113

View more
  197 in total

Review 1.  Small for size liver remnant following resection: prevention and management.

Authors:  Rony Eshkenazy; Yael Dreznik; Eylon Lahat; Barak Bar Zakai; Alex Zendel; Arie Ariche
Journal:  Hepatobiliary Surg Nutr       Date:  2014-10       Impact factor: 7.293

Review 2.  Protection of the liver during hepatic surgery.

Authors:  Pierre-Alain Clavien; Jean Emond; Jean Nicolas Vauthey; Jacques Belghiti; Ravi S Chari; Steven M Strasberg
Journal:  J Gastrointest Surg       Date:  2004 Mar-Apr       Impact factor: 3.452

Review 3.  Preoperative portal vein embolization in liver cancer: indications, techniques and outcomes.

Authors:  Romaric Loffroy; Sylvain Favelier; Olivier Chevallier; Louis Estivalet; Pierre-Yves Genson; Pierre Pottecher; Sophie Gehin; Denis Krausé; Jean-Pierre Cercueil
Journal:  Quant Imaging Med Surg       Date:  2015-10

Review 4.  Systematic review of pathophysiological changes following hepatic resection.

Authors:  Joey Siu; John McCall; Saxon Connor
Journal:  HPB (Oxford)       Date:  2013-08-29       Impact factor: 3.647

5.  Remnant growth rate after portal vein embolization is a good early predictor of post-hepatectomy liver failure.

Authors:  Universe Leung; Amber L Simpson; Raphael L C Araujo; Mithat Gönen; Conor McAuliffe; Michael I Miga; E Patricia Parada; Peter J Allen; Michael I D'Angelica; T Peter Kingham; Ronald P DeMatteo; Yuman Fong; William R Jarnagin
Journal:  J Am Coll Surg       Date:  2014-06-25       Impact factor: 6.113

Review 6.  Optimizing hepatectomy for hepatocellular carcinoma in Asia-patient selection and special considerations.

Authors:  Clarence Nicholas Kotewall; Tan To Cheung
Journal:  Transl Gastroenterol Hepatol       Date:  2018-10-08

7.  A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases.

Authors:  Daniel Jaeck; Elie Oussoultzoglou; Edoardo Rosso; Michel Greget; Jean-Christophe Weber; Philippe Bachellier
Journal:  Ann Surg       Date:  2004-12       Impact factor: 12.969

Review 8.  Portal vein embolization in extended liver resection.

Authors:  Nisha Narula; Thomas A Aloia
Journal:  Langenbecks Arch Surg       Date:  2017-05-31       Impact factor: 3.445

9.  2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma.

Authors: 
Journal:  Gut Liver       Date:  2015-05-23       Impact factor: 4.519

10.  Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: analysis of 1222 consecutive patients from a prospective database.

Authors:  Ronnie T Poon; Sheung Tat Fan; Chung Mau Lo; Chi Leung Liu; Chi Ming Lam; Wai Key Yuen; Chun Yeung; John Wong
Journal:  Ann Surg       Date:  2004-10       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.